HIV Drugs Should Be Initiated Earlier, Says UN
July 19, 2010
All HIV-positive people with a CD4+ T-cell count of 350 cells/mm3 or lower should begin antiretroviral therapy (ART), the World Health Organization said on Monday. WHO released the first revision to its ART recommendations in four years at the 18th International AIDS Conference in Vienna. WHO's revised ART guidelines reiterate advice from 2009 that treatment should begin earlier.
WHO recommendations favor simplified first- and second-line ART regimens of low toxicity and in fixed doses. Initial ART should contain a non-nucleoside reverse transcriptase inhibitor, either nevirapine or efavirenz, plus two nucleoside reverse transcriptase inhibitors, one of which should be lamivudine or emtricitabine and the other zidovudine or tenofovir, the report said.
Agence France Presse
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)